EXAS
Exact Sciences Corp
Price:  
68.36 
USD
Volume:  
2,010,735.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS Relative Valuation

-149.7%
Upside

As of 2024-10-07, the Relative Valuation of Exact Sciences Corp (EXAS) is (33.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.36 USD, the upside of Exact Sciences Corp based on Relative Valuation is -149.7%.

The range of the Relative Valuation is (33.30) - (42.17) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 31.9x - 44.5x 33.9x
Forward P/E multiples 35.2x - 52.7x 37.8x
Fair Price (33.30) - (42.17) (33.95)
Upside -148.7% - -161.7% -149.7%
68.36 USD
Stock Price
(33.95) USD
Fair Price

EXAS Relative Valuation - Historical P/E Data

Date P/E
2024-10-04 -72.18
2024-10-03 -70.12
2024-10-02 -70.63
2024-10-01 -71.84
2024-09-30 -71.92
2024-09-27 -69.64
2024-09-26 -71.73
2024-09-25 -71.55
2024-09-24 -72.57
2024-09-23 -73.53
2024-09-20 -74.00
2024-09-19 -74.78
2024-09-18 -73.07
2024-09-17 -71.78
2024-09-16 -73.36
2024-09-13 -69.20
2024-09-12 -71.15
2024-09-11 -67.70
2024-09-10 -61.64
2024-09-09 -62.07
2024-09-06 -62.41
2024-09-05 -64.31
2024-09-04 -60.32
2024-09-03 -63.36
2024-08-30 -65.13
2024-08-29 -65.74
2024-08-28 -64.56
2024-08-27 -63.23
2024-08-26 -63.18
2024-08-23 -63.03
2024-08-22 -62.36
2024-08-21 -63.01
2024-08-20 -62.10
2024-08-19 -62.26
2024-08-16 -62.03
2024-08-15 -61.73
2024-08-14 -59.51
2024-08-13 -62.10
2024-08-12 -60.72
2024-08-09 -60.19
2024-08-08 -60.46
2024-08-07 -59.12
2024-08-06 -59.08
2024-08-05 -58.88
2024-08-02 -60.55
2024-08-01 -61.14
2024-07-31 -48.23
2024-07-30 -49.18
2024-07-29 -48.10
2024-07-26 -47.83